Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06355258
Status:
RECRUITING
Last Update Posted:
2024-04-09
First Post:
2024-04-06
Brief Title:
A Study of the Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 Patients
Sponsor:
Westlake University
Organization:
Westlake University
Study Overview
Official Title:
A Study of the Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 Patients
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to learn if troxerutin works to prevent thrombotic events in mild or severe COVID-19 patients It will also learn about the safety of troxerutin The main questions it aims to answer are
Does troxerutin lower the number of thrombotic events in participants
What medical problems do participants have when taking troxerutin Researchers will compare troxerutin to a placebo a look-alike substance that contains no drug to see if troxerutin works to prevent thrombotic events in COVID-19 patients
Participants will
Take troxerutin or a placebo every day for 7 days
Visit the clinic at the first fourth seventh and 28th days after enrollment for checkups and tests
Keep a diary of their symptoms and the number of times of thrombotic events bleeding events and type II HIT-related thrombocytopenia
Does troxerutin lower the number of thrombotic events in participants
What medical problems do participants have when taking troxerutin Researchers will compare troxerutin to a placebo a look-alike substance that contains no drug to see if troxerutin works to prevent thrombotic events in COVID-19 patients
Participants will
Take troxerutin or a placebo every day for 7 days
Visit the clinic at the first fourth seventh and 28th days after enrollment for checkups and tests
Keep a diary of their symptoms and the number of times of thrombotic events bleeding events and type II HIT-related thrombocytopenia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None